AIM
SAGE

Aurora Investment Managers’s Sage Therapeutics SAGE Stock Holding History

Aurora Investment Managers’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,470
Closed -$444K – 43
2020
Q1 		$444K Buy
15,470
+2,261
+17% +$131K 0.49% 34
2019
Q4 		$954K Buy
+13,209
New +$1.62M 0.93% 31

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Aurora Investment Managers's SAGE Position: Q2 2020 in Review

Aurora Investment Managers sold out of Sage Therapeutics (SAGE) in Q2 2020, closing a stake of 15,470 shares — an estimated $444K sold.

Aurora Investment Managers first reported a position in SAGE in Q4 2019 and held it in 2 quarters. The position peaked at $954K in Q4 2019. 217 funds tracked by Wall St. Rank hold SAGE as of Q2 2020.

  • Aurora Investment Managers reported no remaining Sage Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Aurora Investment Managers sold 15,470 Sage Therapeutics shares in Q2 2020, an estimated $444K.
  • Aurora Investment Managers first reported a position in Sage Therapeutics in Q4 2019 and held it in 2 quarters.
  • Aurora Investment Managers's Sage Therapeutics position peaked at $954K in Q4 2019.
  • 217 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2020.

Based on Aurora Investment Managers's 13F filing for Q2 2020, filed 3 Aug 2020.